Human Immunodeficiency Virus 1 Protease Inhibitors in Clinical Practice
Open Access
- 9 August 1999
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 159 (15) , 1771-1776
- https://doi.org/10.1001/archinte.159.15.1771
Abstract
THE PROGNOSIS for patients infected with the human immunodeficiency virus (HIV) has improved substantially with the use of protease inhibitors (PIs). This improvement is evident by the resolution of previously untreatable infections1,2 and recent decreases in mortality and hospitalization rates,3,4 and it has been confirmed in controlled trials using both surrogate markers and clinical end points.5-7This publication has 11 references indexed in Scilit:
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadirAIDS, 1998
- Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapyThe Lancet, 1998
- Effect of HAART on natural history of AIDS-related opportunistic disordersThe Lancet, 1998
- Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and AdolescentsPublished by American Psychological Association (APA) ,1998
- Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patientsAIDS, 1997
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996